A Retrospective Study to Determine the Preoperative Bilirubin Level for Conducting Preoperative Biliary Drainage to Reduce Pancreaticoduodenectomy Complications

一项回顾性研究旨在确定术前胆红素水平,以便进行术前胆道引流,从而减少胰十二指肠切除术的并发症

阅读:1

Abstract

BACKGROUND: Preoperative biliary drainage is used to alleviate obstructive jaundice before pancreaticoduodenectomy in jaundiced patients, but its effect on reducing the short-term postoperative complications is still controversial. METHODS: Data were collected retrospectively from patients (n = 292) with benign and malignant diseases around the ampulla who underwent pancreaticoduodenectomy in this study. Intergroup comparisons were performed using statistical methods such as t-tests and chi-square tests. The optimal preoperative total bilirubin was identified through receiver operating characteristic curve analysis. RESULTS: A total of 292 patients (jaundiced patients:141, non-jaundice:151) were collected in this study. Compared with non-jaundice patients, the incidence of postoperative bleeding events (P = 0.004), short-term complications (P = 0.038), and severe short-term complications (P = 0.025) was significantly increased in jaundiced patients. The incidence of short-term postoperative complications in patients with severe jaundice was not statistically different from that in patients with mild jaundice after preoperative biliary drainage. In patients with mild jaundice, there was no statistically significant difference between the direct surgery group and the preoperative biliary drainage group. When the preoperative total bilirubin in preoperative biliary drainage patients decreased to 151.8μmol/L, the incidence of severe short-term postoperative complications was significantly reduced (P = 0.047). CONCLUSION: Preoperative biliary drainage can effectively improve liver function and decrease the short-term complications after pancreaticoduodenectomy for severe jaundiced patients. Routine preoperative biliary drainage is not recommended in patients with mild jaundice. It is recommended to reduce the total bilirubin to less than 151.8μmol/L, which can effectively decrease the severe short-term postoperative complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。